BRIEF published on 01/20/2026 at 07:35, 3 months 28 days ago Investissement de 51 millions d'euros dans Exciva pour traiter Alzheimer Investissement Gimv Alzheimer Biopharmaceutique Essai Clinique
BRIEF published on 01/20/2026 at 07:35, 3 months 28 days ago Gimv Leads €51 Million Investment in Exciva for Alzheimer's Therapy Series B Funding Gimv Investment Exciva GmbH Alzheimer’s Therapy Deraphan Trial
REGULATED PRESS RELEASE published on 01/20/2026 at 07:30, 3 months 28 days ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy Gimv mène une levée de fonds de 51 millions d'euros pour Exciva afin de faire avancer une thérapie innovante contre la maladie d'Alzheimer Investissement Gimv Alzheimer Thérapie Exciva
REGULATED PRESS RELEASE published on 01/20/2026 at 07:30, 3 months 28 days ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy Exciva secures €51m funding led by Gimv and EQT for Alzheimer's therapy. Deraphan targets agitation in Phase II trial, promising improved care for patients Funding Phase II Trial Exciva Alzheimer's Therapy Deraphan
REGULATED PRESS RELEASE published on 01/20/2026 at 07:30, 3 months 28 days ago Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling Gimv Series B EUR 51 Miljoen Exciva Alzheimerbehandeling
BRIEF published on 01/16/2026 at 07:35, 4 months 1 day ago Gimv Sells Majority Stake in ALT Technologies to CCL Industries Acquisition Automotive Industry Gimv CCL Industries ALT Technologies
BRIEF published on 01/16/2026 at 07:35, 4 months 1 day ago Gimv cède sa participation majoritaire dans ALT Technologies à CCL Industries Cession Investissement Industrie Automobile Expansion Mondiale Composants Adhésifs
REGULATED PRESS RELEASE published on 01/16/2026 at 07:30, 4 months 1 day ago Gimv sells majority stake in ALT Technologies to CCL Industries Gimv sells majority stake in ALT Technologies to CCL Industries, a strategic move in the automotive industry Acquisition Automotive Industry Gimv CCL Industries ALT Technologies
REGULATED PRESS RELEASE published on 01/16/2026 at 07:30, 4 months 1 day ago Gimv sells majority stake in ALT Technologies to CCL Industries Gimv sells majority stake in ALT Technologies to CCL Industries, enhancing CCL's capabilities in automotive industry; transaction subject to closing conditions Automotive Industry Gimv Transaction CCL Industries ALT Technologies
REGULATED PRESS RELEASE published on 01/16/2026 at 07:30, 4 months 1 day ago Gimv verkoopt meerderheidsbelang in ALT Technologies aan CCL Industries Gimv verkoopt meerderheidsbelang in ALT Technologies aan CCL Industries, versterkt positie in automobielsector en duurzame toepassingen Gimv CCL Industries ALT Technologies Verkoop Meerderheidsbelang Automobielsector
Published on 05/16/2026 at 01:15, 2 days 1 hour ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 2 days 3 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 2 days 4 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/16/2026 at 16:08, 1 day 11 hours ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 2 days 6 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 2 days 8 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 2 days 12 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 2 days 12 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 17 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days 18 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 4 days 9 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
